Plans & Pricing
Does My Company Subscribe?
For pharmaceutical companies, deploying programmatic technology is a sticky subject. Because of strict privacy and patient protection laws, pharma companies are limited in how they can target individual consumers, which makes programmatic advertising more of a guessing game. But that doesn’t mean it can’t be done. Jack Hogan, CTO at medical publisher Lifescript, spoke with eMarketer’s Maria Minsker about how pharma companies can use publishers’ data to leverage programmatic technology.
eMarketer: How can medical publishers create proxy audiences to power programmatic technology for pharma brands?
Jack Hogan: Medical publishers have vast audiences of opt-in consumers with targetable IDs and declared health interests. We’re talking about first-party data, not third-party health and medical data, which is inaccurate 50% of the time. By decoupling that first-party, declared health data from any private information, publishers enable brands to reach desired audiences with specific medical interests across the entire ad ecosystem—without breaking any HIPAA rules.
What Is the Best Metric for Valuing Ads Across Media for US Agencies and Marketers? (% of respondents, May 2019)
Top 3 KPIs Tracked by US Direct-to-Consumer Brands for TV Ads, Jan 1, 2018-March 31, 2019
Length of TV Ads for US Direct-to-Consumer Brands, Jan 1, 2018-March 31, 2019
Response Rate to TV Ads for US Direct-to-Consumer Brands, by Ad Length, Jan 1, 2018-March 31, 2019
How Much of US TV Advertisers' TV Ad Spending Is Data-Enabled*? (% of total, 2018-2020)
The Brand-Agency Relationship: Streamlining with In-House Teams and Flexible Engagement Models
Customer Experience 2019 (Part 2)—Personalization and Data-Driven Experiences: The Building Blocks of a Better Customer Experience (A 4-Part Series)
How Advertisers Are Navigating Changing Auction Dynamics
How GroupM Utilizes Supply Path Optimization
How Brands Streamline Their Agency Partnerships
Verizon, Chobani and Trunk Club Execs on the Challenges and Successes of Operating In-House Agencies